Executive Moves
Yi Chen New MD in Equity Research in H.C. Wainwright
|
H.C. Wainwright & Co., LLC has appointed Yi Chen, Ph.D as a Managing Director in Equity Research and Senior Biotechnology Analyst.
Growth Capitalist (https://growthcapitalist.com/prominence/category-featured/page/57/)
This will allow you to designate a story to appear more prominently on category archive pages.
H.C. Wainwright & Co., LLC has appointed Yi Chen, Ph.D as a Managing Director in Equity Research and Senior Biotechnology Analyst.
Several states have adopted or are pursuing equity crowdfunding laws amid doubts over the Securities and Exchange Commission’s commitment to approve Title III of the JOBS Act, which along with the proposed Regulation A overhaul, has been in comment period purgatory for more than a year.
A Canadian stock exchange is taking a lead in trying to stop market abuse with shell companies that are using loose regulations to spin-out companies and avoid trading restrictions and reporting requirements.
The Securities and Exchange Commission charged Oppenheimer & Co. with violating federal securities laws while improperly selling penny stocks in unregistered offerings on behalf of customers.